SEC Form 4 · accession 0000905148-26-003044
NextCure, Inc. · NXTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David S Kabakoff
Director
Period of report
Jun 18, 2026
Accepted (ET)
Jun 22, 2026 · 4:14 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001661059
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.02 | Jun 18, 2026 | A | 3,510 | A | — | Jun 17, 2036 | Common Stock | 3,510 | 3,510 | D |
Explanation of responses
- F1The option vests in full on the earlier of June 18, 2027 and the date of the 2027 Annual Meeting of Stockholders.